ARGX:NASDAQ
argenx SE - ADR
928,44 $
arrow_downward
-0,22%(-2,08) 1D
847,72 $
arrow_downward
-8,69% (-80,72)todayPre-market
Closed: 7 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
932,08 $
High
942,68 $
Low
921,72 $
Mkt. cap
58,78 млрд
Avg. vol.
259,69 м.
Volume
1,36 мың
P/E ratio
35,27
52-wk high
1 072,75 $
52-wk low
661,85 $
EPS
26,32 $
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 мың
Open
932,08 $
High
942,68 $
Low
921,72 $
Mkt. cap
58,78 млрд
Avg. vol.
259,69 м.
Volume
1,36 мың
P/E ratio
35,27
52-wk high
1 072,75 $
52-wk low
661,85 $
EPS
26,32 $
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 мың
News stories
From web sources and news partners
Investing.com
·
42 минут бұрын
Why is argenx stock plunging today?
Investing.com
·
44 минут бұрын
Argenx shares plunge 16% after Sjögren’s drug trial halted
AD HOC NEWS
·
2 сағат бұрын
argenx reports positive FB102 Phase 2 results: stock ahead of Xetra open at prior close EUR 829.70
TipRanks
·
2 сағат бұрын
Argenx advances CD122 inhibitor FB102 after positive Phase 2 celiac data
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR